Evolent Health Attracts Private Equity Interest Amid Potential Sale Discussions

Evolent Health is currently in discussions with private equity firms and other companies for a potential sale. Interested parties include private equity firms TPG, CD&R, and KKR, as well as health insurer Elevance Health. The process began following inbound interest, and a deal could be finalized in the coming weeks.

Evolent Health is in advanced discussions with private equity firms and other companies regarding a potential sale, sources confirmed on Thursday. The move follows significant inbound interest, with TPG, CD&R, and KKR among those expressing interest in the $3.3 billion healthcare services provider.

Health insurer Elevance Health is also in the race and may collaborate with a private equity firm to acquire Evolent. Both Evolent and the interested parties declined to comment on the matter.

Evolent is working alongside a financial adviser and has received initial bids. While sources indicate a deal may be reached in the coming weeks, they caution that the outcome remains uncertain due to the confidential nature of the discussions.

(With inputs from agencies.)